Tech Company Financing Transactions
Humacyte Funding Round
Humacyte closed a $37.3 million funding round on 1/22/2014. Backers included private investors.
Transaction Overview
Company Name
Announced On
1/22/2014
Transaction Type
Debt
Amount
$37,262,373
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2525 E NC Hwy. 54
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Overview
Humacyte uses proprietary technology to grow stable, off-the-shelf human tissue replacements such as vein grafts to pre-designed clinical and commercial specifications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Carrie Cox
Chief Executive Officer
Jeffrey Lawson
Founder
Laura Niklason
VP - Bus. Development
Juliana Blum
VP - Regulatory Affairs
William Tente
Browse more venture capital transactions:
Prev: 1/22/2014: Sharethrough venture capital transaction
Next: 1/22/2014: Social Sports Network venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs